Chilton Capital Management LLC Boosts Stock Position in Healthpeak Properties, Inc. $DOC

Chilton Capital Management LLC increased its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 15.8% during the 2nd quarter, Holdings Channel.com reports. The fund owned 426,708 shares of the real estate investment trust’s stock after acquiring an additional 58,285 shares during the period. Chilton Capital Management LLC’s holdings in Healthpeak Properties were worth $9,132,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of DOC. CX Institutional grew its position in Healthpeak Properties by 6.1% in the 2nd quarter. CX Institutional now owns 11,003 shares of the real estate investment trust’s stock valued at $235,000 after acquiring an additional 633 shares in the last quarter. Fiduciary Trust Co increased its stake in Healthpeak Properties by 4.9% during the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after purchasing an additional 644 shares during the period. Patton Fund Management Inc. lifted its position in shares of Healthpeak Properties by 5.2% during the fourth quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after purchasing an additional 648 shares in the last quarter. Quadrant Capital Group LLC lifted its position in shares of Healthpeak Properties by 1.9% during the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock worth $721,000 after purchasing an additional 718 shares in the last quarter. Finally, Quantum Portfolio Management LLC boosted its stake in shares of Healthpeak Properties by 2.5% in the first quarter. Quantum Portfolio Management LLC now owns 29,372 shares of the real estate investment trust’s stock valued at $483,000 after purchasing an additional 728 shares during the period. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Price Performance

Shares of NYSE DOC opened at $20.78 on Friday. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02. The company has a market cap of $14.33 billion, a price-to-earnings ratio of 59.38, a price-to-earnings-growth ratio of 3.20 and a beta of 1.01. The stock’s 50-day moving average is $21.33 and its two-hundred day moving average is $18.90. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $22.95.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The business had revenue of $771.58 million during the quarter, compared to analysts’ expectations of $725.64 million. During the same quarter last year, the business posted $0.46 EPS. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Analysts forecast that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.9%. Healthpeak Properties’s dividend payout ratio (DPR) is 348.57%.

Analyst Ratings Changes

DOC has been the subject of a number of research reports. Royal Bank Of Canada lifted their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Robert W. Baird increased their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a report on Thursday. Citigroup increased their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Tuesday. Scotiabank raised their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 27th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 24th. Four equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $21.44.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.